About the Massey Genome Service
The Massey Genome Service (MGS) operates a traditional Sanger ABI sequencing and genotyping service using two Applied Biosystems Inc. ABI 3730 instruments.
The ABI sequencing and genotyping service started operation back in January 1997 with an ABI 377 instrument which used traditional acrylamide gels. The service then in January 2003 purchased two ABI 3730 capillary instruments, which allowed for a considerable increase in throughput. The service now operates a cost effective, reliable and competitive service and has now incorporated sample preparation automation into its procedures, with the purchase of liquid handling instrumentation, which has allowed for improvements in data quality.
MGS took delivery of an Illumina Genome Analyzer in October 2007 and was the first to purchase and operate a Illumina GA in the Southern hemisphere. We have been leading the way in Next-Generation sequencing since starting commercial operation in May 2008. MGS has temporarily closed the Next-Generation Sequencing Service, with the proposal to implement two Illumina MiSeq instruments and proceed to provide Next-Generation sequencing services towards the end of 2011.
The Illumina MiSeq instrumentation , uses Illumina's massively parallel sequencing-by-synthesis (SBS) technology, generating medium throughput, high-quality DNA sequencing.
The MGS will initially be supports the following GAII sequencing applications:
- Whole Genome Sequencing and Re-sequencing
- mRNA Sequencing
- Small RNA Discovery and Analysis
Indexing tagging and pooling of libraries to maximise lane usage will be available, along with both single read and paired end read sequencing.
